EUVIMEDEUVIMED entdecken
Crossref

Public Health: The Forgotten Dimension of Health Technology Assessment

Mondher Toumi iD, Jaime Espin iD, Bruno Falissard iD, Anna Kapuśniak, Pascal Auquier iD, Laurent Boyer, Claude Dussart iD, Emilia Strycharz-Angrecka, Mariem El Haj

Journal of Evaluation in Clinical Practice · 2026-12 · 32 (8)

DOI: 10.1111/jep.70586 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Evaluation in Clinical Practice, online erschienen am 04.11.2026. Verfasst von Mondher Toumi und 8 weiteren Autor:innen. Beteiligte Einrichtung: Aix-Marseille University, CEReSS - Health Service Research and Quality of Life Center, Marseille, France. Hauptthemen laut MEDLINE: Technology Assessment, Biomedical, Public Health. Die Arbeit nennt 48 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Rationale

Health technology assessment (HTA) is the principal instrument wealthy health systems use to decide what to fund, and it measures the health a technology adds for treated patients rigorously. Yet population‐health considerations—disease burden, prevention, externalities such as herd protection, fairness between groups, and democratically chosen priorities—are weakly built into how HTA judges value. Aims and Objectives To specify the nature of this gap and to offer a conceptual framework that clarifies it: to distinguish three paradigms of value assessment (clinical, cost‐effectiveness and public‐health HTA), and to separate two frequently conflated ideas—respecting public‐health priorities versus yielding to political pressure.

Methods

A conceptual analysis informed by a narrative reading of HTA methodological guidance and the health‐economics, public‐health and priority‐setting literatures.

Results

First, contemporary HTA clusters around two paradigms—clinical assessment and cost‐effectiveness assessment—while a population‐health paradigm is named but instantiated in no major agency's reference case. Second, public‐health objectives (burden, prevention, transmission externalities, distribution, priorities) are only partially operationalised—acknowledged but rarely weighed in the formal value calculation. Third, the three‐paradigm model shows the gap is systematic, not incidental: today's methods ask “how much does it help the patient?” and “how much health per euro?”, seldom “how do we improve population health, fairly?”. Fourth, the gap is tractable—the necessary instruments exist and are compatible with opportunity cost, and two common objections (that QALYs already capture population value, and that priorities equal interference) do not withstand scrutiny.

Conclusion

A public‐health‐informed HTA—explicit disease‐burden assessment, transmission modelling, transparent treatment of priorities and formal equity analysis—could better align appraisal with population health, fairly distributed. We call on EUPHA and HTAi to convene a joint working group.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Technology Assessment, BiomedicalPublic HealthHumansCost-Benefit AnalysisCost-Effectiveness AnalysisHealth PrioritiesQuality-Adjusted Life Years

Stichwörter der Autor:innen

biomedicalcost of illnesshealth equityhealth prioritiespopulation healthpublic healthquality‐adjusted life yearstechnology assessment

Autor:innen und Institutionen

  • Aix-Marseille University, CEReSS - Health Service Research and Quality of Life Center, Marseille, France.
  • Andalusian School of Public Health/Escuela Andaluza de Salud Pública (EASP), Granada, Spain.
  • CIBER of Epidemiology and Public Health (CIBERESP), 28029 Madrid, Spain; Instituto de Investigación Biosanitaria, Granada, Spain.
  • Université Paris-Saclay, CESP, INSERM U1018, Villejuif, France.
  • Clever-Access, Krakow, Poland.
  • University Claude Bernard Lyon 1, Laboratory "Health, Systemic, Process" (P2S), UR4129, University of Lyon, Lyon, France.

ORCID-Profile: Mondher Toumi, Jaime Espin, Bruno Falissard, Pascal Auquier, Claude Dussart

Zitieren

APA

Toumi, M., Espin, J., Falissard, B., Kapuśniak, A., Auquier, P., Boyer, L., Dussart, C., Strycharz-Angrecka, E., & Haj, M. E. (2026). Public Health: The Forgotten Dimension of Health Technology Assessment. Journal of Evaluation in Clinical Practice, 32(8). https://doi.org/10.1111/jep.70586

Vancouver

Toumi M, Espin J, Falissard B, Kapuśniak A, Auquier P, Boyer L, et al. Public Health: The Forgotten Dimension of Health Technology Assessment. Journal of Evaluation in Clinical Practice. 2026;32(8). doi:10.1111/jep.70586

BibTeX
@article{Toumi2026,
  author = {Toumi, Mondher and Espin, Jaime and Falissard, Bruno and Kapuśniak, Anna and Auquier, Pascal and Boyer, Laurent and Dussart, Claude and Strycharz-Angrecka, Emilia and Haj, Mariem El},
  title = {Public Health: The Forgotten Dimension of Health Technology Assessment},
  journal = {Journal of Evaluation in Clinical Practice},
  year = {2026},
  volume = {32},
  number = {8},
  doi = {10.1111/jep.70586}
}
Kostenlos starten →